AIM: This paper synthesizes findings from available research about medication adherence to disease-modifying antirheumatic drugs (DMARDs) in the population with rheumatoid arthritis (RA). RESULTS: This review of literature included 35 articles. Medication adherence to DMARDs ranged from 30% to 107%. Adherence rates of more than 100% indicated that patients took more than the prescribed amount of medication. There were no consistent risk factors for nonadherence to DMARD prescriptions identified, but some evidence was provided for self-efficacy, patient-healthcare provider relationships, social support, patient beliefs about medications, and age as factors affecting medication adherence. Support for educational interventions focused on medication adherence was equivocal. CONCLUSION: Further research is necessary to develop a comprehensive, theoretically based understanding of medication adherence in RA patients.
AIM: This paper synthesizes findings from available research about medication adherence to disease-modifying antirheumatic drugs (DMARDs) in the population with rheumatoid arthritis (RA). RESULTS: This review of literature included 35 articles. Medication adherence to DMARDs ranged from 30% to 107%. Adherence rates of more than 100% indicated that patients took more than the prescribed amount of medication. There were no consistent risk factors for nonadherence to DMARD prescriptions identified, but some evidence was provided for self-efficacy, patient-healthcare provider relationships, social support, patient beliefs about medications, and age as factors affecting medication adherence. Support for educational interventions focused on medication adherence was equivocal. CONCLUSION: Further research is necessary to develop a comprehensive, theoretically based understanding of medication adherence in RApatients.
Authors: D M van der Heijde; M A van 't Hof; P L van Riel; L A Theunisse; E W Lubberts; M A van Leeuwen; M H van Rijswijk; L B van de Putte Journal: Ann Rheum Dis Date: 1990-11 Impact factor: 19.103
Authors: Charles G Helmick; David T Felson; Reva C Lawrence; Sherine Gabriel; Rosemarie Hirsch; C Kent Kwoh; Matthew H Liang; Hilal Maradit Kremers; Maureen D Mayes; Peter A Merkel; Stanley R Pillemer; John D Reveille; John H Stone Journal: Arthritis Rheum Date: 2008-01
Authors: M L Hetland; H M Lindegaard; A Hansen; J Pødenphant; J Unkerskov; V S Ringsdal; M Østergaard; U Tarp Journal: Ann Rheum Dis Date: 2008-02-13 Impact factor: 19.103
Authors: Joyce A Cramer; Anuja Roy; Anita Burrell; Carol J Fairchild; Mahesh J Fuldeore; Daniel A Ollendorf; Peter K Wong Journal: Value Health Date: 2008 Jan-Feb Impact factor: 5.725
Authors: K Kumar; C Gordon; V Toescu; C D Buckley; R Horne; P G Nightingale; K Raza Journal: Rheumatology (Oxford) Date: 2008-03-29 Impact factor: 7.580
Authors: Carlos G Grijalva; Cecilia P Chung; Patrick G Arbogast; Charles M Stein; Edward F Mitchel; Marie R Griffin Journal: Med Care Date: 2007-10 Impact factor: 2.983
Authors: Araceli Garcia-Gonzalez; Marsha Richardson; Maria Garcia Popa-Lisseanu; Vanessa Cox; Michael A Kallen; Namieta Janssen; Bernard Ng; Donald M Marcus; John D Reveille; Maria E Suarez-Almazor Journal: Clin Rheumatol Date: 2008-01-08 Impact factor: 2.980
Authors: Natalia Mena-Vazquez; Sara Manrique-Arija; Lucía Yunquera-Romero; Inmaculada Ureña-Garnica; Marta Rojas-Gimenez; Carla Domic; Francisco Gabriel Jimenez-Nuñez; Antonio Fernandez-Nebro Journal: Rheumatol Int Date: 2017-06-19 Impact factor: 2.631